CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Rolfe Lindsey Director | Grant or award · Stock Option (Right to Buy) | +17,923 | 17,923 | ||
| 2025-03-04 | Byrnes Michael Director | Grant or award · Stock Option (Right to Buy) | +17,923 | 17,923 | ||
| 2025-03-04 | Patel Shami Director | Grant or award · Stock Option (Right to Buy) | +14,936 | 14,936 | ||
| 2025-03-04 | ATWOOD BRIAN G Director | Grant or award · Stock Option (Right to Buy) | +14,936 | 14,936 | ||
| 2025-03-04 | Ehrlich Christopher B Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +119,486 | 119,486 | ||
| 2025-02-24 | Rolfe Lindsey Director | Grant or award · Stock Option (Right to Buy) | +127,500 | 255,000 | ||
| 2025-02-24 | Patel Shami Director | Grant or award · Stock Option (Right to Buy) | +127,500 | 255,000 | ||
| 2025-02-24 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +127,500 | 255,000 | ||
| 2025-02-24 | Ehrlich Christopher B Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +1,275,000 | 2,550,000 | ||
| 2025-02-24 | Byrnes Michael Director | Grant or award · Stock Option (Right to Buy) | +127,500 | 255,000 | ||
| 2025-02-24 | ATWOOD BRIAN G Director | Grant or award · Stock Option (Right to Buy) | +254,000 | 508,000 | ||
| 2025-02-07 | ATWOOD BRIAN G Director | Grant or award · Pre-Funded Warrant | +306,120 | $0.00 | $31 | 306,120 |
| 2025-02-07 | ATWOOD BRIAN G Director | Grant or award · Pre-Funded Warrant | +204,080 | $0.00 | $20 | 204,080 |
| 2025-02-07 | ATWOOD BRIAN G Director | Grant or award · Warrant to Purchase Shares of Common Stock | +306,120 | $1.96 | $600K | 306,120 |
| 2025-02-07 | ATWOOD BRIAN G Director | Grant or award · Warrant to Purchase Shares of Common Stock | +204,080 | $1.96 | $400K | 204,080 |
| 2024-12-13 | YK Bioventures Opportunities GP I, LLC 10% owner | Sale | −2,998,908 | $0.06 | $180K | 13,005,169 |
| 2024-12-12 | YK Bioventures Opportunities GP I, LLC 10% owner | Sale | −1,614,541 | $0.07 | $113K | 16,004,077 |
| 2024-12-11 | YK Bioventures Opportunities GP I, LLC 10% owner | Sale | −1,343,801 | $0.08 | $108K | 17,618,618 |
| 2024-12-10 | YK Bioventures Opportunities GP I, LLC 10% owner | Sale | −1,570,947 | $0.09 | $141K | 18,962,419 |
| 2024-12-09 | YK Bioventures Opportunities GP I, LLC 10% owner | Sale | −850,543 | $0.11 | $94K | 20,533,366 |
Page 2 of 6 · 120 trades